-
Citizens JMP Reiterates Market Outperform Rating on Madrigal Pharmaceuticals (MDGL)
-
Madrigal Pharmaceuticals (MDGL) PT Raised to $469 at Citi
-
Citi Reiterates Buy Rating on Madrigal Pharmaceuticals (MDGL)
-
Citi Closes 30-Day Upside Catalyst Watch on Madrigal Pharmaceuticals (MDGL)
-
Midday movers: Adobe, Zillow fall; Micron rises
-
Madrigal Pharmaceuticals (MDGL) PT Raised to $389 at Citi
-
Citi Starts Madrigal Pharmaceuticals (MDGL) at Buy, Opens 30-Day Upside Catalyst Watch
-
Madrigal Pharmaceuticals (MDGL) PT Lowered to $173 at Citi
-
Madrigal Pharmaceuticals (MDGL) PT Lowered to $186 at Citi
-
Madrigal Pharmaceuticals (MDGL) PT Lowered to $186 at Citi
-
Madrigal Pharmaceuticals (MDGL) Estimate Raised At Citi
-
Madrigal Pharmaceuticals (MDGL) PT Lowered to $200 at Citi
-
Citi Starts Madrigal Pharmaceuticals (MDGL) at Buy
-
Pre-Open Movers 06/06: (AXON) (VBLT) (SIG) Higher; (AMBA) (IMGN) (OLLI) Lower (more...)

